Nathan Dowden

Nathan Dowden

Net worth: 1 M $ as of 2026-06-29

56 year
Commercial Services
Consumer Services
Health Technology

Profile

Nathan J.
Dowden
is President & Chief Operating Officer at Entrada Therapeutics, Inc. since 2024, with employment at Entrada Therapeutics, Inc. starting in 2019.
Former positions include Managing Director at Huron Consulting Group, Inc. from 2014 to 2016; Managing Director at Frankel Group LLC; Senior Consultant at Ernst & Young LLP; Principal at G.D.
Searle & Co., Inc.; Analyst at CIGNA HealthCare, Inc. from 2013 to 2019; and Senior VP-Strategy & Corporate Development at Rubius Therapeutics, Inc. from 2016 to 2019.
Education includes undergraduate studies at the University of Connecticut and an MBA from The University of Chicago Booth School of Business.

Known holdings in public companies

CompanyDateNumber of sharesValuationValuation date
2026-05-03 198,588 ( 0.51% ) 1 M $ 2026-06-29

Nathan Dowden active positions

CompaniesPositionStart
ENTRADA THERAPEUTICS, INC. President 2023-12-31

Former positions of Nathan Dowden

CompaniesPositionEnd
RUBIUS THERAPEUTICS Corporate Officer/Principal 2019-07-24
Corporate Officer/Principal 2018-12-31
HURON CONSULTING GROUP INC. Corporate Officer/Principal 2016-02-29
Frankel Group LLC
Corporate Officer/Principal -
Corporate Officer/Principal -
See the detail of Nathan Dowden's experience

Training of Nathan Dowden

Experiences
Positions held

Active

Inactive

Listed companies

Private companies

Connections

22

1st degree connections

9

1st degree companies

Male

Female

Members of the board

Executives

Linked companies

Private companies9

Commercial Services

Commercial Services

Process Industries

Consumer Services

Health Services

Consumer Services

Health Technology

Health Technology

Frankel Group LLC